To print: Select File and then Print from your browser's menu

Title: Sertraline Is Effective in Treatment of Depression of Older Adults

URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&dopt=Abstract&list_uids=12832242

Am J Psychiatry 2003;160:7:1277-1285. "An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression"
07/21/2003 09:51:01 AM
By Martha Kerr

The selective serotonin reuptake inhibitor sertraline was well tolerated and showed efficacy in the treatment of older adults with depression, according to findings from an 8-week, multicentre trial. Study authors, led by Dr. Lon A. Schneider, University of Southern California in Los Angeles, believe this to be the first placebo-controlled trial of sertraline for older adults with depression. The study randomised 747 outpatients aged 60 and older to sertraline of placebo. All patients had a diagnosis of major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, (DSM-IV), and a Hamilton Depression (HAM-D) Rating Scale score of 18 or greater. A total of 371 patients received sertraline, starting at 50 mg or 100 mg daily, and 376 patients received placebo. HAM-D scores decreased a mean of 7.4 points in the sertraline group and 6.6 points in the placebo group. Clinical response, defined by the Clinical Global Impression scale, occurred in 45% of sertraline-treated patients and in 35% of placebo patients, a difference that was statistically significant. Discontinuation of treatment due to adverse effects occurred in 8% of sertraline-treated patients and in 2% of placebo patients. Dr. Schneider and associates say that the active treatment effect was greater toward the end of the 8-week trial, while improvement levelled off at about 6 weeks in the placebo group. "It may be that treatment of late-life depression, especially in patients with substantial medical co-morbidity, has a longer response latency than is observed in younger adults," they write. The investigators speculate, "improvement in the sertraline group, and a greater drug-placebo difference, may have occurred if the trial had been longer."

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&dopt=Abstract&list_uids=12832242

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.